APO Research

APO RESEARCH · REPORT

Biorepository Services

Selected research

Market Outlook & Growth Opportunities

Global Biorepository Services Market Outlook and Growth Opportunities 2026

Market perspective

The global Biorepository Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Biorepository Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Biorepository Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Biorepository Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Biorepository Services market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Biorepository Services market include Azenta, EPL Archives (VWR), Q2 Lab Solutions, Medpace Labs, Thermo Fisher Scientific, Clinigen, Precision Stability Storage, Precision for Medicine and Kryosphere, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Biorepository Services market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Biorepository Services and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Biorepository Services revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Biorepository Services market.

Biorepository Services Segment by Company

Azenta

EPL Archives (VWR)

Q2 Lab Solutions

Medpace Labs

Thermo Fisher Scientific

Clinigen

Precision Stability Storage

Precision for Medicine

Kryosphere

Cryoport Inc

Masy BioServices (Alcami)

SciSafe (BioLife Solutions)

Cenetron (Versiti Clinical Trials)

Vigilant Bioservices

CellCarta

BioArkive

Tescor

Birka BioStorag

Shanghai Biochip Co

Albetra

Biorepository Services Segment by Type

Room Temperature Storage

Refrigerated Storage

Frozen Storage

Ultra Low Temperature Storage

Liquid Nitrogen Storage

Others

Biorepository Services Segment by Application

Life Sciences

Hospital

Research Institutions

Chemical Industry

Others

Biorepository Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Biorepository Services status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Biorepository Services key companies, revenue, market share, and recent developments.

3. To split the Biorepository Services breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Biorepository Services market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Biorepository Services significant trends, drivers, influence factors in global and regions.

6. To analyze Biorepository Services competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biorepository Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biorepository Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biorepository Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Biorepository Services industry.

Chapter 3: Detailed analysis of Biorepository Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Biorepository Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Biorepository Services in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Biorepository Services Industry Trends Table 2. Biorepository Services Industry Drivers Table 3. Biorepository Services Industry Opportunities and Challenges Table 4. Biorepository Services Industry Restraints Table 5. Global Biorepository Services Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Biorepository Services Revenue Share by Company (2021-2026) Table 7. Global Biorepository Services Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Biorepository Services Key Company Manufacturing Base & Headquarters Table 9. Global Biorepository Services Company, Product Type & Application Table 10. Global Biorepository Services Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Biorepository Services by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Room Temperature Storage Table 15. Significant Companies of Refrigerated Storage Table 16. Significant Companies of Frozen Storage Table 17. Significant Companies of Ultra Low Temperature Storage Table 18. Significant Companies of Liquid Nitrogen Storage Table 19. Significant Companies of Others Table 20. Global Biorepository Services Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 21. Global Biorepository Services Sales Value by Type (2021-2026) & (US$ Million) Table 22. Global Biorepository Services Sales Value by Type (2027-2032) & (US$ Million) Table 23. Global Biorepository Services Sales Value Share by Type (2021-2026) Table 24. Global Biorepository Services Sales Value Share by Type (2027-2032) Table 25. Significant Companies of Life Sciences Table 26. Significant Companies of Hospital Table 27. Significant Companies of Research Institutions Table 28. Significant Companies of Chemical Industry Table 29. Significant Companies of Others Table 30. Global Biorepository Services Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Biorepository Services Sales Value by Application (2021-2026) & (US$ Million) Table 32. Global Biorepository Services Sales Value by Application (2027-2032) & (US$ Million) Table 33. Global Biorepository Services Sales Value Share by Application (2021-2026) Table 34. Global Biorepository Services Sales Value Share by Application (2027-2032) Table 35. Global Biorepository Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Biorepository Services Sales Value by Region (2021-2026) & (US$ Million) Table 37. Global Biorepository Services Sales Value Share by Region (2021-2026) Table 38. Global Biorepository Services Sales Value by Region (2027-2032) & (US$ Million) Table 39. Global Biorepository Services Sales Value Share by Region (2027-2032) Table 40. Global Biorepository Services Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Biorepository Services Sales Value by Country (2021-2026) & (US$ Million) Table 42. Global Biorepository Services Sales Value Market Share by Country (2021-2026) Table 43. Global Biorepository Services Sales Value by Country (2027-2032) & (US$ Million) Table 44. Global Biorepository Services Sales Value Market Share by Country (2027-2032) Table 45. Azenta Company Information Table 46. Azenta Business Overview Table 47. Azenta Biorepository Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Azenta Biorepository Services Product Portfolio Table 49. Azenta Recent Development Table 50. EPL Archives (VWR) Company Information Table 51. EPL Archives (VWR) Business Overview Table 52. EPL Archives (VWR) Biorepository Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. EPL Archives (VWR) Biorepository Services Product Portfolio Table 54. EPL Archives (VWR) Recent Development Table 55. Q2 Lab Solutions Company Information Table 56. Q2 Lab Solutions Business Overview Table 57. Q2 Lab Solutions Biorepository Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Q2 Lab Solutions Biorepository Services Product Portfolio Table 59. Q2 Lab Solutions Recent Development Table 60. Medpace Labs Company Information Table 61. Medpace Labs Business Overview Table 62. Medpace Labs Biorepository Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Medpace Labs Biorepository Services Product Portfolio Table 64. Medpace Labs Recent Development Table 65. Thermo Fisher Scientific Company Information Table 66. Thermo Fisher Scientific Business Overview Table 67. Thermo Fisher Scientific Biorepository Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Thermo Fisher Scientific Biorepository Services Product Portfolio Table 69. Thermo Fisher Scientific Recent Development Table 70. Clinigen Company Information Table 71. Clinigen Business Overview Table 72. Clinigen Biorepository Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Clinigen Biorepository Services Product Portfolio Table 74. Clinigen Recent Development Table 75. Precision Stability Storage Company Information Table 76. Precision Stability Storage Business Overview Table 77. Precision Stability Storage Biorepository Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Precision Stability Storage Biorepository Services Product Portfolio Table 79. Precision Stability Storage Recent Development Table 80. Precision for Medicine Company Information Table 81. Precision for Medicine Business Overview Table 82. Precision for Medicine Biorepository Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Precision for Medicine Biorepository Services Product Portfolio Table 84. Precision for Medicine Recent Development Table 85. Kryosphere Company Information Table 86. Kryosphere Business Overview Table 87. Kryosphere Biorepository Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Kryosphere Biorepository Services Product Portfolio Table 89. Kryosphere Recent Development Table 90. Cryoport Inc Company Information Table 91. Cryoport Inc Business Overview Table 92. Cryoport Inc Biorepository Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Cryoport Inc Biorepository Services Product Portfolio Table 94. Cryoport Inc Recent Development Table 95. Masy BioServices (Alcami) Company Information Table 96. Masy BioServices (Alcami) Business Overview Table 97. Masy BioServices (Alcami) Biorepository Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Masy BioServices (Alcami) Biorepository Services Product Portfolio Table 99. Masy BioServices (Alcami) Recent Development Table 100. SciSafe (BioLife Solutions) Company Information Table 101. SciSafe (BioLife Solutions) Business Overview Table 102. SciSafe (BioLife Solutions) Biorepository Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. SciSafe (BioLife Solutions) Biorepository Services Product Portfolio Table 104. SciSafe (BioLife Solutions) Recent Development Table 105. Cenetron (Versiti Clinical Trials) Company Information Table 106. Cenetron (Versiti Clinical Trials) Business Overview Table 107. Cenetron (Versiti Clinical Trials) Biorepository Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Cenetron (Versiti Clinical Trials) Biorepository Services Product Portfolio Table 109. Cenetron (Versiti Clinical Trials) Recent Development Table 110. Vigilant Bioservices Company Information Table 111. Vigilant Bioservices Business Overview Table 112. Vigilant Bioservices Biorepository Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. Vigilant Bioservices Biorepository Services Product Portfolio Table 114. Vigilant Bioservices Recent Development Table 115. CellCarta Company Information Table 116. CellCarta Business Overview Table 117. CellCarta Biorepository Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. CellCarta Biorepository Services Product Portfolio Table 119. CellCarta Recent Development Table 120. BioArkive Company Information Table 121. BioArkive Business Overview Table 122. BioArkive Biorepository Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 123. BioArkive Biorepository Services Product Portfolio Table 124. BioArkive Recent Development Table 125. Tescor Company Information Table 126. Tescor Business Overview Table 127. Tescor Biorepository Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 128. Tescor Biorepository Services Product Portfolio Table 129. Tescor Recent Development Table 130. Birka BioStorag Company Information Table 131. Birka BioStorag Business Overview Table 132. Birka BioStorag Biorepository Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 133. Birka BioStorag Biorepository Services Product Portfolio Table 134. Birka BioStorag Recent Development Table 135. Shanghai Biochip Co Company Information Table 136. Shanghai Biochip Co Business Overview Table 137. Shanghai Biochip Co Biorepository Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 138. Shanghai Biochip Co Biorepository Services Product Portfolio Table 139. Shanghai Biochip Co Recent Development Table 140. Albetra Company Information Table 141. Albetra Business Overview Table 142. Albetra Biorepository Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 143. Albetra Biorepository Services Product Portfolio Table 144. Albetra Recent Development Table 145. Research Programs/Design for This Report Table 146. Authors List of This Report Table 147. Secondary Sources Table 148. Primary Sources List of Figures Figure 1. Biorepository Services Product Image Figure 2. Global Biorepository Services Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Biorepository Services Market Size (2021-2032) & (US$ Million) Figure 4. Global Biorepository Services Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Room Temperature Storage Image Figure 8. Refrigerated Storage Image Figure 9. Frozen Storage Image Figure 10. Ultra Low Temperature Storage Image Figure 11. Liquid Nitrogen Storage Image Figure 12. Others Image Figure 13. Global Biorepository Services Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 14. Global Biorepository Services Sales Value Share 2021 VS 2025 VS 2032 Figure 15. Global Biorepository Services Sales Value Share by Type (2021-2032) Figure 16. Life Sciences Image Figure 17. Hospital Image Figure 18. Research Institutions Image Figure 19. Chemical Industry Image Figure 20. Others Image Figure 21. Global Biorepository Services Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Biorepository Services Sales Value Share 2021 VS 2025 VS 2032 Figure 23. Global Biorepository Services Sales Value Share by Application (2021-2032) Figure 24. Global Biorepository Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 25. Global Biorepository Services Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 26. North America Biorepository Services Sales Value (2021-2032) & (US$ Million) Figure 27. North America Biorepository Services Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Europe Biorepository Services Sales Value (2021-2032) & (US$ Million) Figure 29. Europe Biorepository Services Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Asia-Pacific Biorepository Services Sales Value (2021-2032) & (US$ Million) Figure 31. Asia-Pacific Biorepository Services Sales Value Share by Country (%), 2025 VS 2032 Figure 32. South America Biorepository Services Sales Value (2021-2032) & (US$ Million) Figure 33. South America Biorepository Services Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Middle East & Africa Biorepository Services Sales Value (2021-2032) & (US$ Million) Figure 35. Middle East & Africa Biorepository Services Sales Value Share by Country (%), 2025 VS 2032 Figure 36. USA Biorepository Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. USA Biorepository Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. USA Biorepository Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Canada Biorepository Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Canada Biorepository Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Canada Biorepository Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Mexico Biorepository Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Mexico Biorepository Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Mexico Biorepository Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Germany Biorepository Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Germany Biorepository Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Germany Biorepository Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. France Biorepository Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. France Biorepository Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. France Biorepository Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. U.K. Biorepository Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. U.K. Biorepository Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. U.K. Biorepository Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Italy Biorepository Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Italy Biorepository Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Italy Biorepository Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Spain Biorepository Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Spain Biorepository Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Spain Biorepository Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Russia Biorepository Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Russia Biorepository Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Russia Biorepository Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Netherlands Biorepository Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Netherlands Biorepository Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Netherlands Biorepository Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Nordic Countries Biorepository Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Nordic Countries Biorepository Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Nordic Countries Biorepository Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. China Biorepository Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. China Biorepository Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. China Biorepository Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Japan Biorepository Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Japan Biorepository Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Japan Biorepository Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. South Korea Biorepository Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. South Korea Biorepository Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. South Korea Biorepository Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. India Biorepository Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. India Biorepository Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. India Biorepository Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Australia Biorepository Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Australia Biorepository Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Australia Biorepository Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Southeast Asia Biorepository Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Southeast Asia Biorepository Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Southeast Asia Biorepository Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Brazil Biorepository Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Brazil Biorepository Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Brazil Biorepository Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Argentina Biorepository Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Argentina Biorepository Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Argentina Biorepository Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Chile Biorepository Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Chile Biorepository Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Chile Biorepository Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Colombia Biorepository Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Colombia Biorepository Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Colombia Biorepository Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Peru Biorepository Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Peru Biorepository Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Peru Biorepository Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Saudi Arabia Biorepository Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Saudi Arabia Biorepository Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Saudi Arabia Biorepository Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Israel Biorepository Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Israel Biorepository Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Israel Biorepository Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. UAE Biorepository Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. UAE Biorepository Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. UAE Biorepository Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Turkey Biorepository Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Turkey Biorepository Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Turkey Biorepository Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Iran Biorepository Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Iran Biorepository Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Iran Biorepository Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Egypt Biorepository Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Egypt Biorepository Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Egypt Biorepository Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Years Considered Figure 121. Research Process Figure 122. Key Executives Interviewed

Scope & coverage.

Types
  • Room Temperature Storage
  • Refrigerated Storage
  • Frozen Storage
  • Ultra Low Temperature Storage
  • Liquid Nitrogen Storage
  • Others
Applications
  • Life Sciences
  • Hospital
  • Research Institutions
  • Chemical Industry
  • Others
Companies covered
  • Azenta
  • EPL Archives (VWR)
  • Q2 Lab Solutions
  • Medpace Labs
  • Thermo Fisher Scientific
  • Clinigen
  • Precision Stability Storage
  • Precision for Medicine
  • Kryosphere
  • Cryoport Inc
  • Masy BioServices (Alcami)
  • SciSafe (BioLife Solutions)
  • Cenetron (Versiti Clinical Trials)
  • Vigilant Bioservices
  • CellCarta
  • BioArkive
  • Tescor
  • Birka BioStorag
  • Shanghai Biochip Co
  • Albetra

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Biorepository Services Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Biorepository Services Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Biorepository Services Market Dynamics
  1. 2.1 Biorepository Services Industry Trends
  2. 2.2 Biorepository Services Industry Drivers
  3. 2.3 Biorepository Services Industry Opportunities and Challenges
  4. 2.4 Biorepository Services Industry Restraints
3 Biorepository Services Market by Company
  1. 3.1 Global Biorepository Services Company Revenue Ranking in 2025
  2. 3.2 Global Biorepository Services Revenue by Company (2021-2026)
  3. 3.3 Global Biorepository Services Company Ranking (2024-2026)
  4. 3.4 Global Biorepository Services Company Manufacturing Base and Headquarters
  5. 3.5 Global Biorepository Services Company Product Type and Application
  6. 3.6 Global Biorepository Services Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Biorepository Services Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Biorepository Services Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Biorepository Services Market by Type
  1. 4.1 Biorepository Services Type Introduction
  2. 4.1.1 Room Temperature Storage
  3. 4.1.2 Refrigerated Storage
  4. 4.1.3 Frozen Storage
  5. 4.1.4 Ultra Low Temperature Storage
  6. 4.1.5 Liquid Nitrogen Storage
  7. 4.1.6 Others
  8. 4.2 Global Biorepository Services Sales Value by Type
  9. 4.2.1 Global Biorepository Services Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Biorepository Services Sales Value by Type (2021-2032)
  11. 4.2.3 Global Biorepository Services Sales Value Share by Type (2021-2032)
5 Biorepository Services Market by Application
  1. 5.1 Biorepository Services Application Introduction
  2. 5.1.1 Life Sciences
  3. 5.1.2 Hospital
  4. 5.1.3 Research Institutions
  5. 5.1.4 Chemical Industry
  6. 5.1.5 Others
  7. 5.2 Global Biorepository Services Sales Value by Application
  8. 5.2.1 Global Biorepository Services Sales Value by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Biorepository Services Sales Value by Application (2021-2032)
  10. 5.2.3 Global Biorepository Services Sales Value Share by Application (2021-2032)
6 Biorepository Services Regional Value Analysis
  1. 6.1 Global Biorepository Services Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Biorepository Services Sales Value by Region (2021-2032)
  3. 6.2.1 Global Biorepository Services Sales Value by Region: 2021-2026
  4. 6.2.2 Global Biorepository Services Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Biorepository Services Sales Value (2021-2032)
  7. 6.3.2 North America Biorepository Services Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Biorepository Services Sales Value (2021-2032)
  10. 6.4.2 Europe Biorepository Services Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Biorepository Services Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Biorepository Services Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Biorepository Services Sales Value (2021-2032)
  16. 6.6.2 South America Biorepository Services Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Biorepository Services Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Biorepository Services Sales Value Share by Country, 2025 VS 2032
7 Biorepository Services Country-level Value Analysis
  1. 7.1 Global Biorepository Services Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Biorepository Services Sales Value by Country (2021-2032)
  3. 7.2.1 Global Biorepository Services Sales Value by Country (2021-2026)
  4. 7.2.2 Global Biorepository Services Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Biorepository Services Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Biorepository Services Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Biorepository Services Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Biorepository Services Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Biorepository Services Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Biorepository Services Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Biorepository Services Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Biorepository Services Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Biorepository Services Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Biorepository Services Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Biorepository Services Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Biorepository Services Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Biorepository Services Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Biorepository Services Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Biorepository Services Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Biorepository Services Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Biorepository Services Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Biorepository Services Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Biorepository Services Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Biorepository Services Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Biorepository Services Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Biorepository Services Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Biorepository Services Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Biorepository Services Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Biorepository Services Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Biorepository Services Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Biorepository Services Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Biorepository Services Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Biorepository Services Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Biorepository Services Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Biorepository Services Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Biorepository Services Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Biorepository Services Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Biorepository Services Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Biorepository Services Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Biorepository Services Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Biorepository Services Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Biorepository Services Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Biorepository Services Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Biorepository Services Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Biorepository Services Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Biorepository Services Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Biorepository Services Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Biorepository Services Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Biorepository Services Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Biorepository Services Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Biorepository Services Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Biorepository Services Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Biorepository Services Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Biorepository Services Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Biorepository Services Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Biorepository Services Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Biorepository Services Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Biorepository Services Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Biorepository Services Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Biorepository Services Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Biorepository Services Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Biorepository Services Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Biorepository Services Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Biorepository Services Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Biorepository Services Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Biorepository Services Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Biorepository Services Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Biorepository Services Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Biorepository Services Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Biorepository Services Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Biorepository Services Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Biorepository Services Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Biorepository Services Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Biorepository Services Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Biorepository Services Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Biorepository Services Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Biorepository Services Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Biorepository Services Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Biorepository Services Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Biorepository Services Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Biorepository Services Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Biorepository Services Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Biorepository Services Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Biorepository Services Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Biorepository Services Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Biorepository Services Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Biorepository Services Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Biorepository Services Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Azenta
  2. 8.1.1 Azenta Company Information
  3. 8.1.2 Azenta Business Overview
  4. 8.1.3 Azenta Biorepository Services Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Azenta Biorepository Services Product Portfolio
  6. 8.1.5 Azenta Recent Developments
  7. 8.2 EPL Archives (VWR)
  8. 8.2.1 EPL Archives (VWR) Company Information
  9. 8.2.2 EPL Archives (VWR) Business Overview
  10. 8.2.3 EPL Archives (VWR) Biorepository Services Revenue and Gross Margin (2021-2026)
  11. 8.2.4 EPL Archives (VWR) Biorepository Services Product Portfolio
  12. 8.2.5 EPL Archives (VWR) Recent Developments
  13. 8.3 Q2 Lab Solutions
  14. 8.3.1 Q2 Lab Solutions Company Information
  15. 8.3.2 Q2 Lab Solutions Business Overview
  16. 8.3.3 Q2 Lab Solutions Biorepository Services Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Q2 Lab Solutions Biorepository Services Product Portfolio
  18. 8.3.5 Q2 Lab Solutions Recent Developments
  19. 8.4 Medpace Labs
  20. 8.4.1 Medpace Labs Company Information
  21. 8.4.2 Medpace Labs Business Overview
  22. 8.4.3 Medpace Labs Biorepository Services Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Medpace Labs Biorepository Services Product Portfolio
  24. 8.4.5 Medpace Labs Recent Developments
  25. 8.5 Thermo Fisher Scientific
  26. 8.5.1 Thermo Fisher Scientific Company Information
  27. 8.5.2 Thermo Fisher Scientific Business Overview
  28. 8.5.3 Thermo Fisher Scientific Biorepository Services Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Thermo Fisher Scientific Biorepository Services Product Portfolio
  30. 8.5.5 Thermo Fisher Scientific Recent Developments
  31. 8.6 Clinigen
  32. 8.6.1 Clinigen Company Information
  33. 8.6.2 Clinigen Business Overview
  34. 8.6.3 Clinigen Biorepository Services Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Clinigen Biorepository Services Product Portfolio
  36. 8.6.5 Clinigen Recent Developments
  37. 8.7 Precision Stability Storage
  38. 8.7.1 Precision Stability Storage Company Information
  39. 8.7.2 Precision Stability Storage Business Overview
  40. 8.7.3 Precision Stability Storage Biorepository Services Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Precision Stability Storage Biorepository Services Product Portfolio
  42. 8.7.5 Precision Stability Storage Recent Developments
  43. 8.8 Precision for Medicine
  44. 8.8.1 Precision for Medicine Company Information
  45. 8.8.2 Precision for Medicine Business Overview
  46. 8.8.3 Precision for Medicine Biorepository Services Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Precision for Medicine Biorepository Services Product Portfolio
  48. 8.8.5 Precision for Medicine Recent Developments
  49. 8.9 Kryosphere
  50. 8.9.1 Kryosphere Company Information
  51. 8.9.2 Kryosphere Business Overview
  52. 8.9.3 Kryosphere Biorepository Services Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Kryosphere Biorepository Services Product Portfolio
  54. 8.9.5 Kryosphere Recent Developments
  55. 8.10 Cryoport Inc
  56. 8.10.1 Cryoport Inc Company Information
  57. 8.10.2 Cryoport Inc Business Overview
  58. 8.10.3 Cryoport Inc Biorepository Services Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Cryoport Inc Biorepository Services Product Portfolio
  60. 8.10.5 Cryoport Inc Recent Developments
  61. 8.11 Masy BioServices (Alcami)
  62. 8.11.1 Masy BioServices (Alcami) Company Information
  63. 8.11.2 Masy BioServices (Alcami) Business Overview
  64. 8.11.3 Masy BioServices (Alcami) Biorepository Services Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Masy BioServices (Alcami) Biorepository Services Product Portfolio
  66. 8.11.5 Masy BioServices (Alcami) Recent Developments
  67. 8.12 SciSafe (BioLife Solutions)
  68. 8.12.1 SciSafe (BioLife Solutions) Company Information
  69. 8.12.2 SciSafe (BioLife Solutions) Business Overview
  70. 8.12.3 SciSafe (BioLife Solutions) Biorepository Services Revenue and Gross Margin (2021-2026)
  71. 8.12.4 SciSafe (BioLife Solutions) Biorepository Services Product Portfolio
  72. 8.12.5 SciSafe (BioLife Solutions) Recent Developments
  73. 8.13 Cenetron (Versiti Clinical Trials)
  74. 8.13.1 Cenetron (Versiti Clinical Trials) Company Information
  75. 8.13.2 Cenetron (Versiti Clinical Trials) Business Overview
  76. 8.13.3 Cenetron (Versiti Clinical Trials) Biorepository Services Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Cenetron (Versiti Clinical Trials) Biorepository Services Product Portfolio
  78. 8.13.5 Cenetron (Versiti Clinical Trials) Recent Developments
  79. 8.14 Vigilant Bioservices
  80. 8.14.1 Vigilant Bioservices Company Information
  81. 8.14.2 Vigilant Bioservices Business Overview
  82. 8.14.3 Vigilant Bioservices Biorepository Services Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Vigilant Bioservices Biorepository Services Product Portfolio
  84. 8.14.5 Vigilant Bioservices Recent Developments
  85. 8.15 CellCarta
  86. 8.15.1 CellCarta Company Information
  87. 8.15.2 CellCarta Business Overview
  88. 8.15.3 CellCarta Biorepository Services Revenue and Gross Margin (2021-2026)
  89. 8.15.4 CellCarta Biorepository Services Product Portfolio
  90. 8.15.5 CellCarta Recent Developments
  91. 8.16 BioArkive
  92. 8.16.1 BioArkive Company Information
  93. 8.16.2 BioArkive Business Overview
  94. 8.16.3 BioArkive Biorepository Services Revenue and Gross Margin (2021-2026)
  95. 8.16.4 BioArkive Biorepository Services Product Portfolio
  96. 8.16.5 BioArkive Recent Developments
  97. 8.17 Tescor
  98. 8.17.1 Tescor Company Information
  99. 8.17.2 Tescor Business Overview
  100. 8.17.3 Tescor Biorepository Services Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Tescor Biorepository Services Product Portfolio
  102. 8.17.5 Tescor Recent Developments
  103. 8.18 Birka BioStorag
  104. 8.18.1 Birka BioStorag Company Information
  105. 8.18.2 Birka BioStorag Business Overview
  106. 8.18.3 Birka BioStorag Biorepository Services Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Birka BioStorag Biorepository Services Product Portfolio
  108. 8.18.5 Birka BioStorag Recent Developments
  109. 8.19 Shanghai Biochip Co
  110. 8.19.1 Shanghai Biochip Co Company Information
  111. 8.19.2 Shanghai Biochip Co Business Overview
  112. 8.19.3 Shanghai Biochip Co Biorepository Services Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Shanghai Biochip Co Biorepository Services Product Portfolio
  114. 8.19.5 Shanghai Biochip Co Recent Developments
  115. 8.20 Albetra
  116. 8.20.1 Albetra Company Information
  117. 8.20.2 Albetra Business Overview
  118. 8.20.3 Albetra Biorepository Services Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Albetra Biorepository Services Product Portfolio
  120. 8.20.5 Albetra Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research